Bimiralisib

Bimiralisib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T2265-1mg 1 mg

7 - 10 business days*

30.00€
TGM-T2265-5mg 5 mg

7 - 10 business days*

69.00€
TGM-T2265-1mL 1 ml (1 mL * 10 mM (in DMSO)) - - -

7 - 10 business days*

76.00€
TGM-T2265-10mg 10 mg

7 - 10 business days*

111.00€
TGM-T2265-25mg 25 mg

7 - 10 business days*

218.00€
TGM-T2265-50mg 50 mg

7 - 10 business days*

357.00€
TGM-T2265-100mg 100 mg

7 - 10 business days*

547.00€
 
Description: Bimiralisib (PI3K-IN-2) is an orally bioavailable pan inhibitor of PI3K and... more
Product information "Bimiralisib"
Description: Bimiralisib (PI3K-IN-2) is an orally bioavailable pan inhibitor of PI3K and inhibitor of the mTOR, with potential antineoplastic activity. PI3K-IN-2 inhibits the PI3K kinase isoforms alpha, beta, gamma and delta and, to a lesser extent, mTOR kinase, which may result in tumor cell apoptosis and growth inhibition in cells overexpressing PI3K/mTOR. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to both chemotherapy and radiotherapy. Target: mTOR, PI3K, S6 Kinase. Smiles: Nc1cc(c(cn1)-c1nc(nc(n1)N1CCOCC1)N1CCOCC1)C(F)(F)F
Keywords: 5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine , PQR309 , PI3K-IN-2
Supplier: TargetMol
Supplier-Nr: T2265

Properties

Application: Targets phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta
MW: 411.38 D
Formula: C17H20F3N7O2
Format: 32160405

Database Information

CAS : 1225037-39-7| Matching products
KEGG ID : K00922 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Bimiralisib"
Write a review
or to review a product.
Viewed